Seasonality Snapshot

Pfizer (PFE)

Pharmaceuticals · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
SEASONAL HEADWIND — August
Strongest Month
November
+5.25% avg · 87% win rate
Weakest Month
January
-1.17% avg · 38% win rate
MonthAvg ReturnWin Rate
January -1.17% 38%
February -0.10% 44%
March +2.13% 69%
April +0.40% 44%
May +1.27% 50%
June -0.92% 56%
July +3.20% 56%
August NOW -0.89% 44%
September -0.62% 47%
October +0.84% 53%
November +5.25% 87%
December +0.05% 47%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Pfizer seasonality — common questions

What is Pfizer's best month historically?
Historically, November has been Pfizer's strongest month, averaging +5.25% with a 87% win rate over 15 years of data. January has been the weakest at -1.17%.
Is Pfizer seasonal?
Pfizer shows a measurable seasonal pattern: its best and worst months differ by 6.42 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Pfizer historically perform in August?
Pfizer is currently in August, which has historically averaged -0.89% with a 44% win rate. That has historically been a seasonally weak window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.